
Metproleap 25mg Tablet SR
Marketer
Medstellar Healthcare Private Limited
Salt Composition
Metoprolol Succinate (25mg)
Overview Metproleap 25mg Tablet SR
Cardiobeta 25mg Extended-Release Tablets are classified as beta-adrenergic blockers. This medication treats hypertension (high blood pressure), angina pectoris (chest pain from heart disease), and cardiac arrhythmias (irregular heartbeat). It's also used for migraine prevention and reducing the risk of future heart attacks and strokes. Cardiobeta 25mg ER may be administered independently or in conjunction with other therapies. Dosage and frequency vary based on the treated condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic effects may take weeks to manifest, and long-term use is often necessary. Continued use is vital, even with symptom improvement, as discontinuation can exacerbate the underlying condition. Common, generally mild and transient, side effects include fatigue, cephalalgia (headache), depressive symptoms, diarrhea, skin rash, bradycardia (slow heart rate), dizziness, and nausea. Less frequent side effects include dyspnea (shortness of breath) and hypotension (low blood pressure). Gradual dose escalation minimizes adverse reactions. Report persistent or bothersome side effects to your physician. Prior to initiating treatment, inform your doctor of any hepatic (liver) impairment. Cardiobeta 25mg ER is contraindicated in individuals with bradycardia, severe peripheral vascular disease, severe congestive heart failure, or hypotension. Pregnant or lactating women require medical consultation before use. Always seek medical advice regarding suitability. Regular blood pressure monitoring ensures treatment effectiveness. Alcohol consumption should be limited due to potential side effect exacerbation.
Primary Ingredients of Metproleap 25mg Tablet SR
No text provided to rephrase.
Uses of Metproleap 25mg Tablet SR
Managing angina pectoris (chest pain from heart disease) | Addressing cardiac arrhythmias | Reducing the risk of myocardial infarction | Hypertension (high blood pressure) management | Migraine prophylaxis
Major Benefits of Metproleap 25mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metproleap 25mg Tablet SR whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and meats, while taking Metproleap 25mg Tablet SR.
Common Side effects of Metproleap 25mg Tablet SR:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metproleap 25mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metproleap 25mg Tablet SR whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, but consistent timing is recommended. High-fat foods, including olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and fatty meats, should be avoided when taking Metproleap 25mg Tablet SR.
How Metproleap 25mg Tablet SR works:
CardioLeap 25mg Extended-Release Tablets are a sustained-release beta-adrenergic blocker with cardioselective action. This medication reduces heart rate and improves the heart's pumping efficiency, enhancing circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metproleap 25mg Tablet SR and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metproleap 25mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metproleap 25mg tablets are likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Taking a Metproleap 25mg sustained-release tablet can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Metproleap 25mg sustained-release tablets are considered safe. No dosage modification is necessary for Metproleap 25mg sustained-release tablets in this population.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Metproleap 25mg sustained-release tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Metproleap 25mg Tablet SR :
Should you forget a Metproleap 25mg Tablet SR dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metproleap 25mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Type of Treatment | HEART |
